O le a le mea na fausia moni e le au su'esu'e a le Iunivesite o Kuiniselani?
Oloa PeptideKamupani Peptide Sili Na fausia e le 'au a Kuiniselani se fa'avae su'esu'ega fa'apipi'i, e le o se microscope ae le o se su'esu'ega. NASTIC, puupuu mo le Nanoscale Spatiotemporal Indexing Clustering, ave fa'amaumauga mole mole ta'itasi ma fa'ailoa ai nanoclusters mai ala o lo'o fa'apipi'i pusa fa'amau i avanoa ma le taimi., fa'aogaina fa'amaufa'ailoga fa'aletonu o r = 1.2 ma t = 20 s, ma lipoti fa'asologa o fuifui, olaga atoa, fua fa'avae ma nofoaga vevela (le uluai pepa metotia NASTIC, 2023).
Fa'apisinisi, o lo'o nofo le tulaga i totonu o le Accretion Bio, na faavaeina ma Polofesa Frederic Meunier ma Dr Tristan Wallis o le Queensland Brain Institute, lagolagoina e UniQuest ma lagolagoina e Antler (le 'au a Kuiniselani Brain Institute, 2026). O le fa'amalolo e fa'atumauina ai le so'otaga fa'ama'i lautele: e faasino i polotini autu ma polotini e fesootai ma faamai, igoa e leai se polotini patino ma upusii leai se fua faatatau. Matou te taofia le tusiga i lena tulaga faʻapitoa.
E moni lava le mamafa o lenei galuega. A 2025 O le Global Burden of Disease forecast o loʻo tuʻuina ai le faʻateleina o Parkinson i 15.6 miliona i 2030, 20.4 miliona i 2040 ma 25.2 miliona i 2050, a 112% tula'i mai 2021, fa'atosina ona o le soifua matua o le faitau aofa'i (GBD 2021 su'esu'ega fa'atatau, 2025).
Aisea le Su'esu'ega, E le o le Microscope, Fa'agata mea e mafai ona e fa'ai'u
<vasega fa'atusa ="blog-siata" style="maualuga-lautele:640px;pito:1.5rem auto;fa'afuainumera-tele:12px;maualuga laina:1.3;lanu:tofi"> <svg viewBox="0 0 560 380" style="maualuga-lautele: 100%; maualuga: ta'avale; vai-aiga: 'Inter', faiga-ui, sans-serif; lanu: #1e293b; --siata-faalogo: #64748e;" matafaioi="img" aria-labelledby="alzheimer-s-candidate-failure-by-phase-2002-2012-title alzheimer-s-candidate-failure-by-phase-2002-2012-desc"> <sitaili> /* E tu'u e le tagata fa'aliliu le siata i totonu o se iframe e uliuli lona pito i tua, ma o le iframe o se foliga ese mai le siata, o fa'amau fo'i pusa mata'itusi na fa'aalia e pei o fa'avaa uliuli fa'ata'ali'oli'o ai (prod 09-22). O le pepa o lo'o i totonu o le iframe e manino ona o le le mafai; o le valiina iinei e aofia ai le elemene pito i tua, ma pe a fa'asinotonu le siata nai lo lena e leai se mea e fetaui. Taofi puipui pito i fafo o lenei poloka: o se sitaili elemene i totonu o le SVG o loʻo faʻavasegaina o mea mai fafo, o lea e lafoa'i ai e le puipui se tasi tulafono uma oi ai. */ html, tino { talaaga: #ffffff; pito: 0; } @media (sili-fa'aitiitiga-gaioiga: faaitiitia) { * { animation: leai se tasi !taua; suiga: leai se tasi !taua; } } </sitaili> <sa'o x="0" y="0" lautele="560" maualuga="380" rx="8" fa'atumu="#ffffff" /> <igoa id="alzheimer-s-candidate-failure-by-phase-2002-2012-title">Le manuia ole sui tauva ole Alzheimer ile vaega, 2002-2012</suafa> <desc id="alzheimer-s-candidate-failure-by-phase-2002-2012-desc">Le manuia ole sui tauva ole Alzheimer ile vaega,, e pei ona taupulepule mai le puna o loo taʻua. Le manuia ole sui tauva ole Alzheimer ile vaega, 2002-2012. fa'amatalaga pa faalava: Vaega 1 72; Vaega 2 92; Vaega 3 98.Punavai: Cummings, Morstorf & Zhong, Su'esu'ega a Alzheimer & Togafitiga 2014.</fa'amatalaga> <tusitusiga x="280.0" y="29" tusi-taula ="ogatotonu" tele-fuafua="18" fua-mamafa="800" fa'atumu="Lanu o iai nei">Le manuia ole sui tauva ole Alzheimer ile vaega, 2002-2012</tusitusiga> <laina x1="145" y1="298.0" x2="510" y2="298.0" taia="Lanu o iai nei" opacity="0.08" /> <laina x1="145" y1="243.0" x2="510" y2="243.0" taia="Lanu o iai nei" opacity="0.08" /> <laina x1="145" y1="188.0" x2="510" y2="188.0" taia="Lanu o iai nei" opacity="0.08" /> <laina x1="145" y1="133.0" x2="510" y2="133.0" taia="Lanu o iai nei" opacity="0.08" /> <laina x1="145" y1="78.0" x2="510" y2="78.0" taia="Lanu o iai nei" opacity="0.08" /> <tusitusiga x="136.0" y="122.2" tusi-taula ="i'uga" tele-fuafua="11" fa'atumu="Lanu o iai nei" opacity="0.8"><sipuni x="136.0" dy="0">Vaega 1</sipuni></tusitusiga> <sa'o x="145" y="78.0" lautele="268.2" maualuga="68.0" rx="4" fa'atumu="#f97316" /> <tusitusiga x="421.2" y="122.2" tele-fuafua="11" fa'atumu="Lanu o iai nei">72</tusitusiga> <tusitusiga x="136.0" y="198.2" tusi-taula ="i'uga" tele-fuafua="11" fa'atumu="Lanu o iai nei" opacity="0.8"><sipuni x="136.0" dy="0">Vaega 2</sipuni></tusitusiga> <sa'o x="145" y="154.0" lautele="342.7" maualuga="68.0" rx="4" fa'atumu="#38bdf8" /> <tusitusiga x="495.7" y="198.2" tele-fuafua="11" fa'atumu="Lanu o iai nei">92</tusitusiga> <tusitusiga x="136.0" y="274.2" tusi-taula ="i'uga" tele-fuafua="11" fa'atumu="Lanu o iai nei" opacity="0.8"><sipuni x="136.0" dy="0">Vaega 3</sipuni></tusitusiga> <sa'o x="145" y="230.0" lautele="365.0" maualuga="68.0" rx="4" fa'atumu="#a78bfa" /> <tusitusiga x="518.0" y="274.2" tele-fuafua="11" fa'atumu="Lanu o iai nei">98</tusitusiga> <tusitusiga x="280.0" y="366" tusi-taula ="ogatotonu" tele-fuafua="10" fa'atumu="tatou(--siata-faalogo, Lanu o iai nei)">Punavai: Cummings, Morstorf & Zhong, Su'esu'ega a Alzheimer & Togafitiga (2014)</tusitusiga> </svg> </fa'atusa>
O amioga su'esu'e o se tasi o sao i le fa'atuatuaina o ata, fa'atasi ma mea mata, mauaina, fa'avasegaina, tulaga faataitai ma au'ili'iliga. Iloilo le filifili fua atoa nai lo le fa'aogaina o le su'ega e na'o le pau lea o le mea e fa'atapula'aina.
Phototoxicity e faalagolago i le umi galu, fua, mamanu fa'aalia, ituaiga sela ma igoa. Vero-cell thresholds e le mafai ona tu'u sa'o i neu. Fua le gafatia ma galuega talafeagai i lalo ole tulaga o le mauaina; effects may be negligible or undetectable within a validated range.
Labeling stoichiometry is the second. Most, if not all, labeling strategies give substoichiometric labeling, and an imprecisely known degree of labeling propagates into every copy-number or concentration figure derived from fluorescence (the ProDOL labeling paper, 2024). If you do not know how many dyes sit on each peptide, you cannot convert intensity into molecules.
O fea Fa'ailoga-Kemisi Su'esu'ega e Mafai Ona E Fa'ailoa Moni?
You can specify the labeling chemistry completely, and you should, because none of it can be recovered from the finished image. The degree of labeling is an average that has to be measured rather than assumed, and the ProDOL work shows it varies with dye, cell line and incubation conditions (the ProDOL labeling paper, 2024).
For labeled peptide probes for live-neuron imaging, o fesuiaiga e suia ai le fua o le lanu e iloagofie ai, fua faatatau o le vali i le peptide, nofoaga conjugation, umi so'otaga ma kemisi, ma le fa'afefea ona aveese o totoe o le vali fua. E suia e mea taitasi le susulu, tineia po o tua, ma e tofu uma i totonu o faʻamatalaga ae le o se talanoaga.
Fesuia'i
Aisea ua suia ai le fua
O le a le mea e fai atu i le fa'atau oloa e fa'amauina
Fa'ailoga lanu
Fa'afiafiaga ma fa'aoso, photostability ma le ROS generation e eseese ile vali
igoa vali, tele, fa'afiafiaga ma le fa'aosoina maualuga
O totoe o le vali e fa'atupuina ai le tua ma fa'ailoga fa'ailoga
Laasaga o le fa'amamāina ma le siaki o totoe o le vali
Mama ma faasinomaga
E le fa'amaonia e se numera HPLC e tasi le fa'atasi
Metotia HPLC fa'atasi ai ma le LC-MS o le conjugate
O la matou galuega fa'ata'ita'iga peptide fa'alelei e aofia ai le FITC, FAM, TAMRA, Cy3, Cy5 ma Cy7 fa'ailoga fa'atasi ma le lisi lautele o suiga, e aofia ai N-terminal acetylation, biotinylation, PEGylation, phosphorylation, cyclization ma fa'ailoga isotopic. O lena lisi e taua iinei ona o le nofoaga conjugation o se filifiliga mamanu, e le o se manatu mulimuli.
E Faapefea le Mama, Fa'asinomaga, Anotusi, Fa'amautu ma Su'ega Su'ega E 'ese'ese?
E lima fesili eseese, ma o se tusi faamaonia e tali ai le tasi e lei taliina se isi. O vaega faʻamatalaga i I Q6B foliga eseese, faasinomaga, mama ma le mama, malosi ma le tele, ma le mautu e fai ma mataupu faavae mo le setiina o faʻamatalaga (1999). Ole ta'iala lava lea e fa'apea ole su'ega fa'asinomaga e matua fa'apitoa i itu uiga ese ole fausaga mole, ma matauina o le mama atoatoa e faigata ona iloa ma faʻalagolago tele i metotia, o lea e fuaina le mama mai se tuufaatasiga o metotia.
O le fa'asa'oga lena i le masani o le talia o le numera tasi o le HPLC e fai ma fa'ailoga lotoa. Ole mama ole peptide ile HPLC e le fa'atatauina le vai ma masima, e le mitiia latalata 220 nm, ma o se numera mama-maualuga o lona uiga laititi e aunoa ma se faʻamaoniga faʻamaonia. O su'esu'ega fa'ata'ita'iga o peptide e tapunia ai le va: I Q2(R2) fa'ataga fa'apitoa e fa'aalia e fa'asaga i se fa'agaioiga fa'apitoa ma fautuaina ai ni fa'atonuga se lua pe sili atu pe a le lava le tasi (vaetamaina Novema 2023). I le faatinoga, fa'atasi le RP-HPLC ma se koluma fa'ailoa, gradient ma su'esu'ega umi galu fa'atasi ma le LC-MS mo le fa'asinomaga ma se su'esu'ega o mea mo le peptide upega.
Afai e lagolagoina e faamaumauga faaeletonika se tuuina atu faatulafonoina, 21 Vaega CFR 11 fa'atulagaina le ta'iala e fa'atatau i ai e le FDA e fa'amaoni ma e mana'omia le malupuipuia, ala su'etusi fa'ailoga taimi. Fesili mo le fa'ailoga peptide fa'amalama e ta'u mai ai metotia ta'itasi, e leai se taunuuga e tasi.
O fea Pulea e Fa'asaoina ai se Ta'utinoga Fa'atatau i Fa'ata'ita'iga-Fa'a'au?
E talia e le tagata su'esu'e se tagi fa'amau pe a le fa'aaofia e fa'atonuga le mea fa'ameamea, e le o le taimi e mataina ai le ata. O ta'iala autasi mo se su'esu'ega vaila'au e fa'atulaga ai le pa e tatau ona mama le su'ega lava ia: malosi i lalo 100 nM i su'esu'ega biochemical ma lalo 1 µM i sela, filifilia e sili atu i le 30-paiga i totonu o le aiga fa'amoemoe, ma faʻamaoniga tuusaʻo o le faʻaogaina o le taulaʻi i totonu o sela (Le vaitau o su'esu'ega vaila'au maualuga, 2022). O le iloiloga lava lea e tasi o loʻo faʻamauina ai le vaivai, fa'aputuga e le filifilia ua fa'atupuina le tele o fa'ai'uga sese i tusitusiga, which is why the control set below is the part of a package we would question first.
The Chemical Probes Portal’s validation guidance treats a labeled reagent as something that must pass as both a measurement reagent and a chemical probe: target-dependent signal under assay conditions, engagement at usable concentrations, selectivity, and a link from engagement to function. A bright or biologically active signal on its own does not get there (Chemical Probes Portal FAQ, 2021).
The five controls we would ask to see
Matched unlabeled peptide, same sequence and lot lineage
Negative-control peptide, scrambled or binding-deficient
Free-dye-only and label-only arms at matched concentration
Target-absent or binding-deficient condition
Orthogonal confirmation of engagement, independent of the fluorophore
Fa'aaogā fa'atonuga e fetaui ma le tagi ma ta'u mai isi mea e le'i fo'ia. O se fa'atonuga fa'atonu e misi e mafai ona fa'atapula'aina le mautinoa, ae le mafai ona fa'aitiitia fa'ainisinia uma i'uga i le fa'ama'oti e le fa'apitoa pe a fa'ailoa e isi fa'amaoniga fa'amaonia le le mautonu.. Fausia PeptideM Peptides Gaosi
O le a le Suia e Lenei mo Polokalama a Alzheimer ma Parkinson, ma O le a le mea e tatau ona e faʻamaonia pe a oka?
Na te suia le tulaga faʻamaoniga muamua i le mauaina, e le o le ma'i biology. Na maua se tusiga igoa e sefulu tausaga o faʻataʻitaʻiga a Alzheimer 244 fa'aputuga su'esu'e i le va 2002 ma 2012 ma le tasi ua faamaonia, a 0.4% fua faatatau manuia, ma 72% o sui tauva ua toilalo i le Vaega 1, 92% i le Vaega 2 ma 98% i le Vaega 3 (o le faitau sefulu tausaga le umi o faʻataʻitaʻiga a Alzheimer, 2014). Ole tele ole attrition e tupu a'o le'i o'o ile falema'i taugata tuai, o le mea tonu lava lea o se masini, e tatau ona maua lona tulaga le faitau-cell faitau.
A e fa'atonuina se su'esu'ega peptide fa'ailoga mo lenei galuega, fa'ailoa le afifi, e le na o le faasologa. Fesili atu mo le nofoaga conjugation ma le sootaga, le fua faatatau o le vali-i-peptide ma lona metotia, LC-MS o le conjugate, RP-HPLC ma koluma, gradient ma le umi galu ua ta'ua, upega peptide i totonu, fa'asagatau ma TFA totoe, se siaki solubility i lau su'ega su'ega, ma se talaaga mautu-faailoa.
Afai o lou tulaga
Ona manaʻomia lea
O le a liua le faailo i le numera kopi
Fua le fua o le vali i le peptide fa'atasi ai ma le fa'aigoaina-lelei fa'atonutonu
Ole su'ega e latalata ile tapula'a ole malosi
Fa'amauina fa'atasi le mama ma le fa'asinomaga, e le na'o le eria pasene
Fa'atauga umi pe fa'aauau
Reported light dose and a phototoxicity control
Multi-lot or multi-site study
Lot-specific CoA with method identifiers and a stability profile
Regulated submission expected
Audit-trailed electronic records under 21 Vaega CFR 11
MOL Changes runs organic and biological teams in-house, with solid-phase, liquid-phase and combined synthesis plus microbial fermentation, and production from milligram to kilogram scale. For probe work that means the modification, the fluorescent label and the analytical package can be specified together, with repeated testing through each process and lot-specific documentation.
Fesili e Fai soo
E lava le maualuga o le HPLC mama e agavaa ai se vaega su'esu'e?
Leai. Purity is highly method-dependent and is properly estimated by a combination of methods (I Q6B, 1999). Area percent at 220 nm also ignores water and salts, so pair it with LC-MS identity and a content assay.
O le a le pepa e tasi e tatau ona ou talosagaina muamua?
O le tusi fa'apitoa fa'apitoa o au'ili'iliga fa'atasi ai ma auala e iloagofie ai: koluma, gradient, umi galu, Faiga MS ma le fua fa'ailoga. O se taunuuga e aunoa ma lona auala e le mafai ona toe gaosia pe puipuia.
Fa'ai'uga
O le tulafono fa'ai'uga matou te fa'aaogaina e faigofie. Talia le tele pe a fa'amaonia le fa'asinomaga e ala ile tele spectrometry, o le mama e lipotia ma lona auala ma faʻapipiʻi ma se suʻega o mea, fua le fua faatatau o le vali i le peptide, o lo'o iai le fa'atonuga lelei o le fa'ailoga, ma o le fua mama o loʻo lipotia i se siaki phototoxicity. Teena, pe toe agavaa, pe a misi se tasi o na mea, aua o le ata o le a foliga faatalitonuina pea.
Afai o lo'o e fausia se polokalame fa'ata'ita'i-neuron fa'ata'amilo i fa'ailoga peptide su'esu'e, e mafai e la matou 'au ona tu'ufa'atasia se pusa fa'ailoga su'esu'e ma se fa'ata'ita'iga CoA fa'apitoa e fa'atatau i nei ta'iala. Ta'u mai lau faasologa, fa'ailoga ma su'esu'ega fa'amau, ma o le a matou taʻuina atu ia te oe le mea e mafai ma e le mafai ona lagolagoina e faʻamaumauga.
Fa'asalalauga fa'asalalau: MOL Changes e tu'uina atu auaunaga peptide ma e iai sona fiafiaga fa'apisinisi i lenei autu. O fa'asologa o auaunaga ma fa'amatalaga o agava'a o fa'atauga a tagata fa'atau; avanoa ma fa'atinoga mo se faufale fa'apitoa e mana'omia ai fa'amaoniga fa'apitoa-poloketi.
Fualaau fou R&D TekinisiaTomai Autu: Su'esu'ega sini, mafutaga fa'a-gaioiga (SAR) au'ili'iliga, peptide-fualaau fa'atasi (PDCs), ma le atinaʻeina o anti-matua ma metabolic peptides.
Tala'aga: O Xiaoxia Chen na taʻitaʻia le suʻesuʻega muamua ma suʻesuʻega faʻapitoa mo le tele o vailaʻau peptide e faʻatatau i le gasegase ma le tuma.. E le gata o ia e atamai i suʻesuʻega maualuga o faletusi peptide ae faʻapitoa foʻi i le faʻaaogaina o le biology computational fesoasoani AI mo le de novo peptide sequence design.. I le taimi nei, o lo'o ia ta'ita'ia se 'au fa'apitoa mo su'esu'ega loloto ma le atina'eina o agonists multifunctional e sosoo ai (pei o le lua- po'o peptide fa'aitiitiga ga'o fa'a-tolu-fa'atatau) ma peptides e toe fa'aleleia ai le tino malosi.
Talofa lava! 👋 Fa'afeiloa'i i Suiga MOL. E mafai faapefea ona matou fesoasoani ia te oe i le aso? Lagona le saoloto e fesili e uiga i la matou peptide synthesis, auaunaga CRO, poʻo soʻo se faʻamatalaga o oloa - naʻo le taina o lau feʻau i lalo ma o le a matou faʻaauau le talanoaga ile WhatsApp.
